Description
Linawalk-M Tablets are an advanced oral anti-diabetic medication that combines the benefits of Linagliptin (DPP-4 inhibitor) and Metformin (biguanide). This dual-action therapy helps in lowering blood glucose levels, improving insulin sensitivity, and reducing HbA1c in patients with Type 2 Diabetes Mellitus.
Key Ingredients & Composition (per tablet):
-
Linagliptin IP – 2.5 mg / 5 mg (strength as per pack)
-
Metformin Hydrochloride IP – 500 mg / 850 mg / 1000 mg (strength as per pack)
Benefits:
-
Improves glycemic control in Type 2 Diabetes
-
Enhances insulin sensitivity & pancreatic function
-
Lowers fasting and postprandial blood glucose
-
Reduces risk of diabetes-related complications
Indications:
-
Type 2 Diabetes Mellitus (as part of diet & exercise regimen)
Packaging & Price:
-
Pack: [Insert pack size, e.g., 10×10 Tablets]
-
MRP: [Insert price, e.g., ₹—/Box]
-
GST: 12%
Storage:
Store in a cool & dry place. Protect from direct sunlight.
Disclaimer:
To be taken under medical supervision only. Not recommended for patients with Type 1 Diabetes or diabetic ketoacidosis.
Franchise Enquiry
Biophar Lifesciences Pvt. Ltd. offers PCD Pharma Franchise and Third-Party Manufacturing Services for diabetic and nutraceutical ranges. With WHO-GMP certified manufacturing, timely delivery, and strong marketing support, we provide a reliable business opportunity.
